Åse Rosenqvist

Nordic Business Unit Lead Cell Therapy • Janssen

Mrs. Rosenqvist holds a position on the Board of CAMP ATMP Sweden and serves as the Nordic Cell Therapy lead at Janssen, a division of Johnson&Johnson. Her expertise lies in guiding pharmaceutical companies toward innovative approaches in Europe. She excels at fostering collaboration among various stakeholders within the healthcare system, academia, universities, authorities, and the life science sector. Through her inclusive and inspiring leadership style, she empowers individuals and harnesses their potential.

Also speaking

Michal Besser

Chief Technology Officer, Davidoff Cancer Center • Rabin Medical Center

Simon Hort

Team Leader Adaptive Production Control • Fraunhofer

Theres Oakes

Head of Product Characterisation • Achilles Therapeutics

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.